Elsevier

Data in Brief

Volume 43, August 2022, 108415
Data in Brief

Data Article
Monoclonal antibodies binding data for SARS-CoV-2 proteins

https://doi.org/10.1016/j.dib.2022.108415Get rights and content
Under a Creative Commons license
open access

Abstract

SARS-CoV-2 pandemic opens up the curiosity of understanding the coronavirus. This demand for the development of the regent, which can be used for academic and therapeutic applications. The present data provide the biochemical characterization of synthetically developed monoclonal antibodies for the SARS-CoV-2 proteins. The antibodies from phage-displayed antibody libraries were selected with the SARS-CoV-2 proteins immobilized in microwell plates. The clones which bind to the antigen in Fab-phage ELISA were selected, and a two-point competitive phage ELISA was performed. Antibodies binding kinetic of IgGs for SARS-CoV2 proteins further carried with B.L.I. Systematic analysis of binding with different control proteins and purified SARS-CoV-2 ensured the robustness of the antibodies.

Keywords

ELISA
B.L.I.
SARS-CoV-2

Cited by (0)